The association of free testosterone levels with coronavirus disease 2019

Tugce Apaydin1, Bahadır Sahin2, Saida Dashdamirova1

  • 1Department of Endocrinology and Metabolism, Marmara University School of Medicine, Istanbul, Turkey.

Andrology
|January 7, 2022
PubMed
Abstract

Insights

Coronavirus disease 2019 significantly impacts male reproductive health, causing widespread hypogonadism and low testosterone. These hormonal changes correlate with disease severity and may persist long-term, affecting fertility.

Area of Science:

  • Endocrinology
  • Virology
  • Reproductive Health

Background:

  • Angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) are key to SARS-CoV-2 entry.
  • ACE2 expression is highest in testes, suggesting potential testicular impact from COVID-19.
  • Low testosterone is linked to infections, potentially worsening COVID-19 outcomes via cytokine storms.

Purpose of the Study:

  • To assess acute and chronic effects of COVID-19 on male gonadal function.
  • To investigate the relationship between free testosterone levels and COVID-19 prognosis.
  • To determine if low free testosterone impacts intensive care unit (ICU) admission rates.

Main Methods:

  • Observational study of 81 RT-PCR confirmed COVID-19 patients.
  • Measurement of serum hormones including FSH, LH, SHBG, and total testosterone.
  • Follow-up assessments at 6 months for 29 patients, including semen analysis for 7.

Main Results:

  • 71.6% of patients presented with low free testosterone (secondary hypogonadism in 69%).
  • Low testosterone group showed longer hospitalization and higher inflammatory markers (d-dimer, hs-CRP, procalcitonin).
  • ICU-admitted patients had lower testosterone levels; free testosterone inversely correlated with hospitalization length and disease severity. Oligozoospermia and impaired motility observed in 42.8% of semen analyses.

Conclusions:

  • High prevalence of hypogonadism (71.6%) observed in COVID-19 patients, with persistent issues in ~50% at 6 months.
  • Low free testosterone is associated with inflammation and increased ICU admission risk.
  • Further long-term studies are needed to clarify persistent hypogonadism and spermatogenesis impairment.